Wolverine Trading, LLC Immunic, Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $94.2 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.0 - $5.49 $40,200 - $73,566
13,400 New
13,400 $42,000
Q2 2022

Aug 15, 2022
SELL
$3.13 - $12.25 $41,629 - $162,925
-13,300 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$9.54 - $14.26 $26,711 - $39,928
-2,800 Reduced 17.39%
13,300 $154,000
Q2 2021

Aug 06, 2021
BUY
$11.76 - $16.85 $189,336 - $271,285
16,100 New
16,100 $198,000

Others Institutions Holding IMUX

# of Institutions
67
Shares Held
56M
Call Options Held
4.7K
Put Options Held
311K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $36.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email